Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: Implications for histogenesis

International Journal of Experimental Pathology

Volumn 95, Issue 3, 2014, Pages 191-198

  Santos, Nuno P ^a,b   Oliveira, Paula A ^a,c   Arantes Rodrigues, Regina ^a,b   Faustino Rocha, Ana I ^a   Colaço, Aura ^a,b   Lopes, Carlos ^d,e   Gil da Costa, Rui M ^d,e  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^d PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

Cytokeratin; Hepatic progenitor cell; Hepatocellular carcinoma; Histogenesis; Liver; N diethylnitrosamine

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 7; DIETHYLNITROSAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DEDIFFERENTIATION; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; HISTOGENESIS; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER INJURY; MALE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TISSUE SECTION;

CYTOKERATIN; HEPATIC PROGENITOR CELL; HEPATOCELLULAR CARCINOMA; HISTOGENESIS; LIVER; N-DIETHYLNITROSAMINE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DIETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; KERATIN-19; KERATIN-7; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED ICR; PRECANCEROUS CONDITIONS;

EID: 84900485588     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12082     Document Type: Article

References (29)

1. Anderson J., Loi R., Perra A. et al. (2010) Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology 51, 1401-1409.
2. Calvisi D.F., Ladu S., Gorden A. et al. (2006) Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 130, 1117-1128.
3. Deschl U., Cattley R., Harada T. et al. (2001) Liver, Glaabladder, and Exocrine Pancreas. In: International Classification of Rodent Tumors: The Mouse, pp. 59-86 (ed. U. Mohr ), Heidelberg: Springer-Verlag.
4. Ding S.J., Li Y., Tan Y.X. et al. (2004) From proteomic analysis to clinical significance - overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol. Cell. Proteomics 3, 73-81.
5. Dumble M.L., Croager E.J., Yeoh G.C.T. & Quail E.A. (2002) Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis 23, 435-445.
6. Durnez A., Verslype C., Nevens F. et al. (2006) The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 49, 138-151.
7. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C. & Parkin D.M. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917.
8. Goldfarb S., Pugh T.D., Koen H. & He Y.Z. (1983) Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy. Environ. Health Perspect. 50, 149-161.
9. Hecht S.S., Mirvish S.S., Gold B., Nagel D., Magee P.N. (1989) Conference on advances in the biology and chemistry of N-nitroso and related-compounds. Cancer Res. 49, 1327-1329.
10. Heindryckx F., Colle I. & Van Vlierberghe H. (2009) Experimental mouse models for hepatocellular carcinoma research. Int. J. Exp. Pathol. 90, 367-386.
11. Heindryckx F., Kuchnio A., Casteleyn C. et al. (2012) Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice. J. Hepatol. 57, 61-68.
12. Kakehashi A., Kato A., Inoue M. et al. (2010) Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions. Toxicol. Appl. Pharmacol. 242, 47-55.
13. Kang J.S., Wanibuchi H., Morimura K., Gonzalez F.J. & Fukushima S. (2007) Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res. 67, 11141-11146.
14. Kawai M., Saegusa Y., Kemmochi S. et al. (2010) Cytokeratin 8/18 is a useful immunohistochemical marker for hepatocellular proliferative lesions in mice. J. Vet. Med. Sci. 72, 263-269.
15. Kim H., Park C., Han K.H. et al. (2004) Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J. Hepatol. 40, 298-304.
16. Kushida M., Kamendulis L.M., Peat T.J. & Klaunig J.E. (2011) Dose-related induction of hepatic preneoplastic lesions by diethylnitrosamine in C57BL/6 mice. Toxicol. Pathol. 39, 776-786.
17. Lee J.S., Heo J., Libbrecht L. et al. (2006) A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat. Med. 12, 410-416.
18. Libbrecht L., Desmet V., Van Damme B. & Roskams T. (2000) The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J. Hepatol. 33, 76-84.
19. Motola-Kuba D., Zamora-Valdés D., Uribe M. & Méndez-Sánchez N. (2006) Hepatocellular carcinoma. An overview. Ann. Hepatol. 5, 16-24.
20. Sakamoto M., Hirohashi S. & Shimosato Y. (1991) Early stages of multistep hepatocarcinogenesis - adenomatous hyperplasia and early hepatocellular-carcinoma. Hum. Pathol. 22, 172-178.
21. Shibuya M., Kondo F., Sano K., Takada T. & Asano T. (2011) Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma. J. Hepatobiliary Pancreat. Sci. 18, 537-543.
22. Stahl S., Ittrich C., Marx-Stoelting P. et al. (2005) Genotype-phenotype relationships in hepatocellular tumors from mice and man. Hepatology 42, 353-361.
23. Strnad P., Stumptner C., Zatloukal K. & Denk H. (2008) Intermediate filament cytoskeleton of the liver in health and disease. Histochem. Cell Biol. 129, 735-749.
24. Uenishi T., Kubo S., Yamamoto T. et al. (2003) Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 94, 851-857.
25. Vaneyken P., Sciot R. & Desmet V.J. (1989) A cytokeratin immunohistochemical study of cholestatic liver-disease - evidence that hepatocytes can express bile duct-type cytokeratins. Histopathology 15, 125-135.
26. Vesselinovitch S.D. & Mihailovich N. (1983) Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res. 43, 4253-4259.
27. Vesselinovitch S.D., Koka M., Mihailovich N. & Rao K.V.N. (1984) Carcinogenicity of diethylnitrosamine in newborn, infant, and adult mice. J. Cancer Res. Clin. Oncol. 108, 60-65.
28. Wang Q., Lin Z.Y. & Feng X.L. (2001) Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection. World J. Gastroenterol. 7, 335-339.
29. Zatloukal K., Stumptner C., Fuchsbichler A. et al. (2004) The keratin cytoskeleton in liver diseases. J. Pathol. 204, 367-376.